Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Age and Refraction in Predicting Myopia Progression With Risk Under COVID-19 in a 3-year Follow-up of a Chinese Cohort

NCT05305274 is registered in ClinicalTrials.gov with Tianjin Eye Hospital as lead sponsor.

NCT NCT05305274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Age and Refraction in Predicting Myopia Progression With Risk Under COVID-19 in a 3-year Follow-up of a Chinese Cohort
Lead sponsor
Tianjin Eye Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
December 1, 2021
Enrollment
34,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia, refraction error